Incidence of preliminary cervical cancer decreased by approximately 80% among women aged 20-24 years in the United States since the widespread use of the human papillomavirus (HPV) vaccine ...

In the U.S., the HPV vaccine has been credited with a 79% reduction in the incidence of cervical precancer in women ages 20-24. Introduced in 2006, the HPV vaccine initially was approved only for ...

This survey investigates the knowledge, attitudes, and intentions of US Hispanic parents surrounding the HPV vaccine.

FIVE AT 535 ON YOUR HEALTH TONIGHT, EXCEPT ANGEL RESULTS FOR A VACCINE THAT’S OFFERED TO MIDDLE SCHOOLERS IN THE U.S. HERE TO EXPLAIN IS DOCTOR SCOTT HADLAND, CHIEF OF ADOLESCENT AND YOUNG ADULT ...

A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary Robert F. Kennedy Jr., is preventing cervical cancer in young women.

Women in their 20s are the group most likely to have been given the HPV vaccine, which has been recommended in the U.S. since 2006 for girls at age 11 or 12 and since 2011 for boys the same age.